Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
09/2012
09/06/2012US20120225883 Compounds for inflammation and immune-related uses
09/06/2012US20120225879 Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases
09/06/2012US20120225876 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
09/06/2012US20120225854 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
09/06/2012US20120225852 Use of steroid compounds
09/06/2012US20120225834 Ocular iontophoresis of charged micelles containing bioactive agents
09/06/2012US20120225827 Silicone-based ophthalmic formulations
09/06/2012US20120225808 Pharmaceutical Composition for Preventing / Treating TRPV1 Activity-Related and Inflammation-Related Diseases or Conditions Containing Maillard Peptide Separated from Well-Aged Traditional Soy Sauce as Active Ingredient
09/06/2012US20120225114 Modifying Macrophage Phenotype for Treatment of Disease
09/06/2012US20120225097 Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
09/06/2012US20120225088 Compositions and methods for treating cancer and other diseases
09/06/2012US20120225081 Vegf-binding molecules
09/06/2012US20120225057 Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
09/06/2012US20120225049 Fast acting snare-cleaving enzymes
09/06/2012US20120225032 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
09/06/2012US20120225031 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
09/05/2012EP2495319A1 INTEGRIN alpha8beta1-SPECIFIC MONOCLONAL ANTIBODY
09/05/2012EP2494954A2 Ophthalmic composition based on lactobionic acid useful for reducing corneal edema and inflammation
09/05/2012EP2493480A1 Ophthalmic formulation and method of manufacture thereof
09/05/2012EP2493475A2 Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye
09/05/2012EP2493293A1 Methods for maintaining eye health and ameliorating opthalmic maladies in canines
09/05/2012CN1955170B Class I tanshinone II A derivative and its application in pharmacy
09/05/2012CN1526023B Use of primer and probe of aldose reductase gene in preparing composition for determination of risk factors for cataract
09/05/2012CN102656172A 8-oxodihydropurine derivative
09/05/2012CN102656161A 2,6-diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
09/05/2012CN102656149A Benzamide compound
09/05/2012CN102655854A Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
09/05/2012CN102653515A Polycationic compounds and uses thereof
09/05/2012CN102652770A Jujube dead leaf wine
09/05/2012CN102247394B Medical application of Harpagoside ingredient
09/05/2012CN102205057B Preparation method of traditional Chinese medicine for treating conjunctival congestion type infant influenza
09/05/2012CN102188558B Method for preparing traditional Chinese medicine for treating pharyngalgia otitis media
09/05/2012CN101744817B Tetrandrine for treating keratopathy
09/05/2012CN101683458B Application of a traditional Chinese medicine composition in preparation of medicament for treating vertigo
09/05/2012CN101632781B Application of Chinese medicinal composition in preparing medicament for treating xerophthalmia
09/05/2012CN101583377B Treatment of fibrosis
09/05/2012CN101534812B Use of L-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases
09/04/2012US8258288 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
09/04/2012US8258142 Substituted 8-[6-amino-3-pyridyl]xanthines
09/04/2012US8258141 Organic compounds
09/04/2012US8257745 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
09/04/2012CA2471812C Targeted retrograde gene delivery to motor neurons
08/2012
08/30/2012WO2012115244A1 Method of producing retinal pigment epithelial cell sheet
08/30/2012WO2012115182A1 Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient
08/30/2012WO2012113894A1 Pharmaceutical combination of betahistine and trimetazidine
08/30/2012US20120220961 Ophthalmic Solutions
08/30/2012US20120220651 Desferrioxamine-metal complexes for the treatment of immune-related disorders
08/30/2012US20120220637 Ophthalmologic Compositions And Use Mode Thereof
08/30/2012US20120220612 Pharmaceutical comprising ppar agonist
08/30/2012US20120220611 1,3-benzoxazolyl derivatives as kinase inhibitors
08/30/2012US20120220606 New capped pyrazinoylguanidine sodium channel blockers
08/30/2012US20120220592 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
08/30/2012US20120220591 Pyrimidone compounds
08/30/2012US20120220586 Heterocyclic compounds and their uses
08/30/2012US20120220585 Heterocyclic compounds and their uses
08/30/2012US20120220564 Selective calcium channel modulators
08/30/2012US20120220555 Methods of Simultaneously Treating Ocular Rosacea and Acne Rosacea
08/30/2012US20120220554 Combretastatins for Prevention of Posterior Capsule Opacification
08/30/2012US20120220543 Treatment of Glaucoma and Other Retinopathies with Gangliosides
08/30/2012US20120219737 Production of extracellular matrix, conditioned media and uses thereof
08/30/2012US20120219627 Compositions and improved soft tissue replacement methods
08/30/2012US20120219623 Pharmaceutical compositions comprising bi-1356 and metformin
08/30/2012US20120219611 Hypotensive lipid-containing biodegradable intraocular implants and related methods
08/30/2012US20120219592 Use of B-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain
08/30/2012US20120219573 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
08/30/2012US20120219567 Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
08/30/2012US20120219546 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors
08/30/2012US20120219498 Compositions and methods for inducing angiogenesis
08/30/2012CA2828197A1 Method of producing retinal pigment epithelial cell sheet
08/29/2012EP2492269A1 Aminothiazole derivative
08/29/2012EP2491930A1 Pharmaceutical combination of betahistine and trimetazidine
08/29/2012EP2490722A2 Modulation of gel temperature of poloxamer-containing formulations
08/29/2012EP2490686A1 The new application of 2-pyrrolidone derivatives
08/29/2012CN1636594B Angiostatin and use of the same for inhibition of angiogenesis
08/29/2012CN102652022A Pharmaceutical composition for treatment of dry eye syndrome
08/29/2012CN102648968A External traditional Chinese medicine composition for eye health
08/29/2012CN102648948A Fumigation Chinese medicinal composition for eye protection
08/29/2012CN102648927A Production technology of petasites lactone compound
08/29/2012CN102648906A Application of sunitinib in preparation of acetylcholinesterase inhibitor
08/29/2012CN102648903A Preparation method for beta-cyclodextrin inclusion compound of beta-carotene
08/29/2012CN102648894A Eye-purposed in-vivo gel preparation prepared from pH (Potential Of Hydrogen) sensitive type baicalin
08/29/2012CN102258709B Traditional Chinese medicine preparation for treating diabetic retinopathy, and preparation method thereof
08/29/2012CN102188637B Traditional Chinese drug composition for treating macular degeneration, and preparation method thereof
08/29/2012CN102058579B Application of dehydrocostuslactone to preparing drug for inhibiting angiogenesis
08/29/2012CN102008470B Compound preparation and use thereof for preventing and treating noise induced hearing damage
08/29/2012CN101321742B Compositions and methods of treating retinal disease
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252815 Nociceptin analogs
08/28/2012US8252793 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
08/28/2012US8252307 Method for treating and/or preventing retinal diseases with sustained release corticosteroids
08/28/2012CA2455776C Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/25/2012CA2731871A1 Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders
08/23/2012WO2012112918A1 Methods for treating diseases of the retina
08/23/2012WO2012112699A2 Method and apparatus for the delivery of photo-chemical (cross-linking) treatment to corneal tissue
08/23/2012WO2012112543A2 Method and apparatus for the delivery of photo-chemical (cross-linking) treatment to scleral tissue
08/23/2012WO2012111878A1 Pharmaceutical composition containing the superoxide dismutase fusion protein for preventing or treating eye diseases
08/23/2012WO2012111877A1 Eye drop composition containing a fusion protein for the fk506 binding protein for preventing or treating eye diseases
08/23/2012WO2012111643A1 Adiponectin production promoter, and medicinal composition, food, drink and feed containing adiponectin production promoter
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 531